PICALM protein level is decreased in the affected brain areas of various tau-related neurodegenerative diseases, including AD, FTLD-tau-MAPT, corticobasal degeneration (CBD) and Lewy body dementia (LBD) diffuse type with tau pathology [33,134,135]. This evidence concerns the gene MAPT and Alzheimer disease.